# Pancap Pharma Inc. – FDA Inspection, Oct 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/pancap-pharma-inc/3968f986-3f6e-4395-834b-dae595f986a6
Source feed: FDA_Inspections

> FDA inspection 1223511 of Pancap Pharma Inc., October 27, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223511
- Company Name: Pancap Pharma Inc.
- Inspection Date: 2023-10-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 939627 - 2015-08-12
- [FDA Inspection 853248 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/pancap-pharma-inc/e9f4da28-66dd-4b74-a733-aca8eef7d8be)
- FDA Inspection 712332 - 2011-02-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.keypedia.com/companies/pancap-pharma-inc/35191643-eacf-4359-ab5e-9d0d23f110ba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c